ThermoFisher (TMO) Offering Possible 11.11% Return Over the Next 17 Calendar Days

ThermoFisher’s most recent trend suggests a bullish bias. One trading opportunity on ThermoFisher is a Bull Put Spread using a strike $480.00 short put and a strike $460.00 long put offers a potential 11.11% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $480.00 by expiration. The full premium credit of $2.00 would be kept by the premium seller. The risk of $18.00 would be incurred if the stock dropped below the $460.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for ThermoFisher is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for ThermoFisher is bullish.

The RSI indicator is above 80 which suggests that the stock is in overbought territory.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for ThermoFisher

S&P Joins NASDAQ at New Highs After Infrastructure Agreement
Fri, 25 Jun 2021 13:15:01 +0000
S&P Joins NASDAQ at New Highs After Infrastructure Agreement

Agilent (A) Expands Presence in LC Market With New Systems
Wed, 23 Jun 2021 14:15:02 +0000
Agilent (A) expands its Bio Liquid Chromatography solutions portfolio with three new systems to fulfil the needs of biopharma industry.

Here’s How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today
Wed, 23 Jun 2021 12:30:12 +0000
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Thermo Fisher (TMO) Invites Applications for Oncomine Program
Tue, 22 Jun 2021 16:00:04 +0000
Thermo Fisher (TMO) to review research proposals eligible for the Oncomine Clinical Research Grant program.

Thermo Fisher’s (TMO) New Launch Boosts Preclinical Development
Mon, 21 Jun 2021 12:30:12 +0000
Thermo Fisher’s (TMO) enhanced Quick to Clinic solution provides balance of speed and quality to accelerate and advance DNA to Investigational New Drug in as less as 13 months.

Be Sociable, Share!

Related Posts